CERHR conclusions would have been strengthened by a more explicit weight-of-evidence analysis.
Gradient Corporation,Cambridge, MA, USA. lrhomberg@gradientcorp.com
Lorenz R
LR
Rhomberg
Julie E
JE
Goodman
D000014:Abnormalities, Drug-Induced / Q000209:etiology* / Q000517:prevention & control*; D000284:Administration, Oral; D000818:Animals; D001559:Benzhydryl Compounds; D003627:Data Interpretation, Statistical; D016208:Databases, Factual; D004781:Environmental Exposure; D004968:Estrogens, Non-Steroidal / Q000009:adverse effects / Q000493:pharmacokinetics / Q000633:toxicity*; D005260:Female; D006801:Humans; D008297:Male; D010636:Phenols / Q000009:adverse effects / Q000493:pharmacokinetics / Q000633:toxicity*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced; D012098:Reproduction / Q000187:drug effects; D012107:Research Design; D012306:Risk; D000098826:Bisphenol A Compounds
D001559:Benzhydryl Compounds; D004968:Estrogens, Non-Steroidal; D010636:Phenols; C006780:bisphenol A; D000098826:Bisphenol A Compounds